Jong-Hwa Park
Director/Board Member at CLINOMICS INC.
Net worth: 3 M $ as of 30/04/2024
Profile
Jong-Hwa Park is currently the Chief Executive Officer at Geromics, Inc. and the Director at Clinomics, Inc. He has an undergraduate degree from the University of Aberdeen and a doctorate degree from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CLINOMICS, INC.
7.38% | 30/04/2024 | 2,453,373 ( 7.38% ) | 3 M $ | 30/04/2024 |
Jong-Hwa Park active positions
| Companies | Position | Start |
|---|---|---|
| CLINOMICS INC. | Director/Board Member | 01/09/2018 |
Geromics, Inc.
 Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Chief Executive Officer | - |
Training of Jong-Hwa Park
| University of Aberdeen | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLINOMICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Geromics, Inc.
Geromics, Inc. Miscellaneous Commercial ServicesCommercial Services Geromics, Inc. engages in the research and development of bio technologies. Its services include bio information technology, genetic test, life science research support, and others. The company was founded on November 18, 2014 and is headquartered in Ulsan, South Korea. | Commercial Services |
- Stock Market
- Insiders
- Jong-Hwa Park